• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bcl-XL保护胰腺腺癌细胞免受CD95和TRAIL受体介导的细胞凋亡。

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.

作者信息

Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H

机构信息

Research Unit Molecular Oncology, Clinic for General Surgery and Thoracic Surgery, Christian-Albrechts-University, Kiel, Germany.

出版信息

Oncogene. 2000 Nov 16;19(48):5477-86. doi: 10.1038/sj.onc.1203936.

DOI:10.1038/sj.onc.1203936
PMID:11114725
Abstract

In this study we sought to clarify the role of the proapoptotic potential of mitochondria in the death pathway emanating from the TRAIL (APO-2L) and CD95 receptors in pancreatic carcinoma cells. We focused on the role of the Bcl-2 family member Bcl-XL, using three pancreatic carcinoma cell lines as a model system, two of which have high (Panc-1, PancTuI) and one has low (Colo357) Bcl-XL expression. In these cell lines, the expression of Bcl-XL correlated with sensitivity to apoptosis induced by TRAIL or anti-CD95. Flow cytometric analysis revealed cell surface expression of TRAIL-R1 and TRAIL-R2 on PancTuI and Colo357, and TRAIL-R2 on Panc-1 cells. In Colo357 cells retrovirally transduced with Bcl-XL, caspase-8 activation in response to treatment with TRAIL or anti-CD95 antibody was not different from parental cells and EGFP-transfected controls, however, apoptosis was completely suppressed as measured by the mitochondrial transmembrane potential deltapsim, caspase-3 activity (PARP cleavage) and DNA-fragmentation. Inhibition of Bcl-XL function by overexpression of Bax or administration of antisense oligonucleotides against Bcl-XL mRNA resulted in sensitization of Panc-1 cells to TRAIL and PancTuI cells to anti-CD95 antibody-induced cell death. The results show that Bcl-XL can protect pancreatic cancer cells from CD95- and TRAIL-mediated apoptosis. Thus, in these epithelial tumour cells the mitochondrially mediated 'type II' pathway of apoptosis induction is not only operative regarding the CD95 system but also regarding the TRAIL system.

摘要

在本研究中,我们试图阐明线粒体促凋亡潜能在源自TRAIL(APO-2L)和CD95受体的胰腺癌细胞死亡途径中的作用。我们以三种胰腺癌细胞系作为模型系统,聚焦于Bcl-2家族成员Bcl-XL的作用,其中两种细胞系Bcl-XL表达水平高(Panc-1、PancTuI),一种表达水平低(Colo357)。在这些细胞系中,Bcl-XL的表达与对TRAIL或抗CD95诱导的凋亡的敏感性相关。流式细胞术分析显示,PancTuI和Colo357细胞表面表达TRAIL-R1和TRAIL-R2,Panc-1细胞表面表达TRAIL-R2。在用Bcl-XL进行逆转录病毒转导的Colo357细胞中,对TRAIL或抗CD95抗体处理的反应中,caspase-8激活与亲代细胞和EGFP转染对照无差异,然而,通过线粒体跨膜电位Δψm、caspase-3活性(PARP裂解)和DNA片段化检测,凋亡被完全抑制。通过过表达Bax或给予针对Bcl-XL mRNA的反义寡核苷酸抑制Bcl-XL功能,导致Panc-1细胞对TRAIL敏感,PancTuI细胞对抗CD95抗体诱导的细胞死亡敏感。结果表明,Bcl-XL可保护胰腺癌细胞免受CD95和TRAIL介导的凋亡。因此,在这些上皮肿瘤细胞中,线粒体介导的“II型”凋亡诱导途径不仅在CD95系统中起作用,在TRAIL系统中也起作用。

相似文献

1
Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.Bcl-XL保护胰腺腺癌细胞免受CD95和TRAIL受体介导的细胞凋亡。
Oncogene. 2000 Nov 16;19(48):5477-86. doi: 10.1038/sj.onc.1203936.
2
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.CD95和TRAIL受体介导的蛋白激酶C和核因子κB激活有助于胰腺导管腺癌细胞的凋亡抵抗。
Oncogene. 2001 Jul 12;20(31):4258-69. doi: 10.1038/sj.onc.1204559.
3
Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.通过抑制酪蛋白激酶II使肿瘤细胞对Apo2配体/TRAIL诱导的凋亡致敏。
Cancer Res. 2002 Aug 1;62(15):4180-5.
4
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.主要的Bcl-XL基因敲低会破坏抗凋亡机制:基于肿瘤坏死因子相关凋亡诱导配体的三联化疗克服了胰腺癌细胞的体外化疗耐药性。
Cancer Res. 2005 Mar 15;65(6):2344-52. doi: 10.1158/0008-5472.CAN-04-3502.
5
G-protein signaling abnormalities mediated by CD95 in salivary epithelial cells.唾液上皮细胞中CD95介导的G蛋白信号异常。
Cell Death Differ. 2000 Nov;7(11):1119-26. doi: 10.1038/sj.cdd.4400745.
6
Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.一氧化氮通过使核因子-κB失活和抑制Bcl-xl表达,使前列腺癌细胞系对TRAIL介导的凋亡敏感。
Oncogene. 2004 Jun 24;23(29):4993-5003. doi: 10.1038/sj.onc.1207655.
7
Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.DLD1人结肠癌细胞系中对腺病毒介导的促凋亡基因治疗产生抗性的相关机制。
Gene Ther. 2002 Sep;9(18):1262-70. doi: 10.1038/sj.gt.3301797.
8
Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.酪蛋白激酶II在肿瘤坏死因子相关凋亡诱导配体诱导人横纹肌肉瘤细胞凋亡中的作用
Clin Cancer Res. 2004 Oct 1;10(19):6650-60. doi: 10.1158/1078-0432.CCR-04-0576.
9
Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.酪蛋白激酶I通过调节Fas相关死亡结构域和procaspase-8向死亡诱导信号复合物的募集来减弱肿瘤坏死因子相关凋亡诱导配体诱导的凋亡。
Cancer Res. 2004 Nov 1;64(21):8036-44. doi: 10.1158/0008-5472.CAN-04-0762.
10
Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.内源性Bcl-xL表达对MKN-45人胃癌细胞凋亡的调控
Oncogene. 1998 Nov 19;17(20):2585-91. doi: 10.1038/sj.onc.1202194.

引用本文的文献

1
The Innate Immune System and the TRAIL-Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females.先天性免疫系统与TRAIL-Bcl-XL轴介导肺癌中的性别差异并赋予女性治疗易感性。
Cancer Res. 2024 Dec 16;84(24):4140-4155. doi: 10.1158/0008-5472.CAN-24-0585.
2
Targeting apoptotic pathways for cancer therapy.针对癌症治疗的凋亡途径。
J Clin Invest. 2024 Jul 15;134(14):e179570. doi: 10.1172/JCI179570.
3
Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells.
获得性硼替佐米耐药非小细胞肺癌细胞中TRAIL敏感性逆转的潜在机制。
Cancer Drug Resist. 2024 Apr 9;7:12. doi: 10.20517/cdr.2024.14. eCollection 2024.
4
TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.肿瘤坏死因子相关凋亡诱导配体:非凋亡信号。
Cells. 2024 Mar 16;13(6):521. doi: 10.3390/cells13060521.
5
Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review).外泌体递送 TRAIL 和 miR-335 用于治疗肝细胞癌 (综述)。
Int J Mol Med. 2023 Jan;51(1). doi: 10.3892/ijmm.2022.5206. Epub 2022 Nov 23.
6
Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries.利用 TRAIL 诱导的细胞死亡进行癌症治疗:充满惊险发现的漫长之旅。
Cell Death Differ. 2023 Feb;30(2):237-249. doi: 10.1038/s41418-022-01059-z. Epub 2022 Oct 4.
7
Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells.内源性肿瘤坏死因子相关凋亡诱导配体受体4(TRAIL-R4)对癌细胞中凋亡和非凋亡性TRAIL诱导的信号传导具有关键影响。
Front Cell Dev Biol. 2022 Sep 9;10:942718. doi: 10.3389/fcell.2022.942718. eCollection 2022.
8
MMP-7 marks severe pancreatic cancer and alters tumor cell signaling by proteolytic release of ectodomains.MMP-7 标记严重的胰腺癌,并通过蛋白水解释放细胞外结构域来改变肿瘤细胞信号。
Biochem Soc Trans. 2022 Apr 29;50(2):839-851. doi: 10.1042/BST20210640.
9
The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab.CCN1 在食管腺癌中的作用:我们从实验室学到了什么。
Cancer Control. 2022 Jan-Dec;29:10732748221074734. doi: 10.1177/10732748221074734.
10
Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells.细胞外pH对胰腺导管腺癌细胞中凋亡性和非凋亡性TRAIL诱导信号传导的影响
Front Cell Dev Biol. 2022 Feb 24;10:768579. doi: 10.3389/fcell.2022.768579. eCollection 2022.